Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
Vorankündigung — Öffnung erwartet am 15. Januar 2027
National Institutes of Health plant 23 Förderungen mit bis zu 150.000 $ pro Projekt bei einem Gesamtbudget von 5,4 Mio. $. Dies ist eine Vorankündigung: Der Fördergeber hat die Ausschreibung angekündigt, sie ist aber noch nicht geöffnet; Veröffentlichung voraussichtlich um den 15. Januar 2027, voraussichtliche Frist 4. Juni 2027. Antragsberechtigte Gruppen laut Quelle: Special district governments, Public housing authorities/Indian housing authorities, Independent school districts und 12 weitere.
Frist
Voraussichtlich 4. Juni 2027 (noch nicht bestätigt)
Öffnet
15. Januar 2027
Fördersumme
bis zu 150.000 $ pro Projekt
Gesamtbudget
5,4 Mio. $
Förderquote
Kein Pflicht-Eigenanteil angegeben; Förderquote nicht angegeben
Gesamtbudget
5,4 Mio. $
Erwartete Förderungen
23
Eigenanteil
Nicht erforderlich
Wahrscheinliche Antragstellende
Öffentliche Stellen, Gemeinnützige, Hochschulen & Forschung, KMU / Start-ups, Unternehmen Aus Quellkategorien oder Programmregeln; maßgeblich ist die Ausschreibung.
Die offiziellen Beschreibungen sind in der Sprache des Fördergebers (meist Englisch); Zusammenfassung und Eckdaten auf dieser Seite sind auf Deutsch.
Über diese Ausschreibung
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing to develop innovative technologies for cancer research or clinical care. The emphasis of this NOFO is on early-stage projects proposing proof-of-concept/pilot studies to test the technical feasibility of the proposed method, tool, assay, platform, or instrument.
Well-suited applications must offer a high degree of technical innovation and the potential to accelerate and/or enhance research in the areas of cancer biology, early detection and screening, clinical diagnosis, treatment, cancer control, and/or epidemiology. Projects that are in-scope include technologies with new or significantly improved technical capabilities to measure, analyze, model, or interrogate cancer-related systems. These may include, but are not limited to, advanced molecular and cellular analysis platforms, multi-omic and spatial profiling methods, imaging and sensing technologies, immuno-engineering approaches, and innovations in biospecimen processing, modeling, and quality assessment. Technologies proposed for development may have potential for widespread applicability but must be focused in this proposal on cancer applications.
Vollständigen Text lesen
This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.
Wer kann sich bewerben?
Special district governments
Public housing authorities/Indian housing authorities
Independent school districts
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled "Additional Information on Eligibility" for clarification)
State governments
County governments
Small businesses
Native American tribal governments (Federally recognized)
City or township governments
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Antragstellerkategorien sind nur ein Ausgangspunkt. Über die Antragsberechtigung entscheidet die offizielle Ausschreibung.
Themen
Health
So bewerben Sie sich
Read the full notice of funding opportunity (NOFO) linked from the official page: eligibility, cost sharing and evaluation criteria.
Make sure your organisation has an active SAM.gov registration and Unique Entity ID (UEI); registration can take several weeks.
For NIH: the organisation and the principal investigator also need eRA Commons accounts; applications are usually submitted through Grants.gov (for example with ASSIST).
Prepare the required forms, narrative, budget and attachments exactly as the NOFO specifies.
Submit before the deadline and keep the tracking number. Check for amendments before you submit.
From the call text
Who can apply
Not stated in the call text we hold — check the official page
Company stage
Not stated in the call text we hold — check the official page
Single applicant or consortium
Not stated in the call text we hold — check the official page
Where applicants must be based
Not stated in the call text we hold — check the official page
Where to apply
Not stated in the call text we hold — check the official page
Die Angaben auf dieser Seite stammen aus der offiziellen Quelle und wurden zuletzt am 15. November 2026 geprüft. Maßgeblich sind immer die Unterlagen des Fördergebers einschließlich späterer Änderungen.
Weitere Ausschreibungen: National Institutes of Health
The purpose of this Notice of Funding Opportunity (NOFO) is to invite Small Research Grant (R21) applications that propose to study the ethical, legal, and social implica…
The goal of this notice of funding opportunity (NOFO) is to support feasibility trials of complementary and integrative health approaches with physical and/or psychologic…
This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated fully remotely delivered and conducted clinical trials to assess the efficacy…
This notice of funding opportunity (NOFO) invites applications for investigator-initiated clinical trials of complementary and integrative health approaches with physical…
This Notice of Funding Opportunity (NOFO) focuses on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD) throughout the lifespan. The inten…